NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

STAAR Surgical Company (STAA) Stock Analysis

STAAR Surgical Company (STAA) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

STAA

$21.61

−$0.71 (−3.18%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare STAA with… →

STAA Key Statistics

As of Oct 21, 2026
Trading
Open
$22.04
Previous Close
$22.32
Day's Range
21.50–22.31
52-Week Range
15.59–35.87
Volume
338.44K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.18
Valuation
Market Cap
$1.08B
P/E Ratio
270.13
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
19.44
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.76
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.19
EPS (ttm)Profit attributable to each share over the last twelve months.
0.08
Financials (FY)
Revenue (FY)
$239.44M−23.72%
Net Income (FY)
−$80.45M
Profit marginThe share of revenue left as profit after all costs and taxes.
1.13%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
50.14M
1-Year Return
−19.03%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
926.71K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, STAA closed at $21.61, −19.03% over 1 year.

STAAR Surgical Company (STAA) has a market capitalization of $1.08B.

In fiscal 2025, STAA reported revenue of $239.44M.

STAA Stock Return by Calendar Year

STAAR Surgical Company (STAA) 10-year return: what $10,000 became

1 year
$10,000 $8,097
−19.03%
5 years
$10,000 $1,713
−82.87%
10 years
$10,000 $22,868
+128.68%

If you had invested $10,000 in STAAR Surgical Company (STAA) 10 years ago, at the close on October 21, 2016, it would have been worth $22,868 at the close on October 21, 2026: +128.68% in total, +8.62% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−6.41%
2025−4.94%
2024−22.17%
2023−35.70%
2022−46.83%
2021+15.25%
2020+125.25%
2019+10.22%
2018+105.87%
2017+42.86%
2016 (partial year)+29.94%

As of October 21, 2026.

STAA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$239.44M−$80.45M−33.6%
2024$313.90M−$20.21M−6.4%
2023$322.42M$21.35M6.6%
2022$284.39M$39.67M13.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$239.44M$182.42M−$45.95M−$80.45M−33.6%
2024$313.90M$239.58M−$12.61M−$20.21M−6.4%
2023$322.42M$252.65M$28.10M$21.35M6.6%
2022$284.39M$223.38M$43.80M$39.67M13.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

STAA Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricSTAAMedical Instruments & Supplies medianvs median
P/E270.1331.198.7x the median
P/S ratio3.192.6023% above
Profit margin1.13%1.62%0.5 pts below

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

STAAR Surgical Company (STAA) is capitalised at $1.08B on the latest close. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 921.

The 52-week range on file runs from $15.59 to $35.87. STAA last closed at $21.61 on October 21, 2026. That is −$0.71 (−3.18%) against the previous close. The latest close sits 38.61% above that 52-week low.

Financial Health

In fiscal 2025, STAAR Surgical Company reported revenue of $239.44M. That is −23.72% against the prior fiscal year, when revenue was $313.90M. The same year closed with a net loss of $80.45M. Profit margin runs at 1.13%. That is 0.5 percentage points below the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 0.08.

Across the 4 fiscal years on file, revenue moves from $284.39M in 2022 to $239.44M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 270.13. That is 8.7 times the Medical Instruments & Supplies median of 31.19. The forward P/E on file is 19.44. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.76. Measured against sales, the shares trade at 3.19 times revenue. On price-to-sales that is 22.84% above the Medical Instruments & Supplies median of 2.6. The medians here are taken across 50 Medical Instruments & Supplies companies that report the metric.

The reported beta is 1.18. Annualized volatility over the trailing 10 years is 58.25%. The trailing one-year total return is −19.03%. Measured over 10 years, that is +8.62% a year compounded.

Growth & Income

No dividend is on file for STAA.

Across the complete calendar years on file, 2020 returned +125.25% and 2022 returned −46.83%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the total return is −6.41% year to date.

Peer Comparison

STAAR Surgical Company (STAA) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
STAAR Surgical Company STAA $1.08B 270.1
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. STAAR Surgical Company trades at a P/E of 270.1.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Visit website →